Skip to content

Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients With a CROS Device on the Contralateral Ear

Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients Using Either a Conventional Hearing Aid or a CROS Device on the Contralateral Ear

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03867396
Enrollment
40
Registered
2019-03-08
Start date
2019-01-23
Completion date
2021-02-11
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Sensorineural

Keywords

Cochlear Implant, Hearing Loss, Hearing Aids, Hearing Tests

Brief summary

Speech understanding in noise remains the greatest challenge for people using cochlear implants, particularly when the speech of interest comes from the side of the head opposite to the implant. Recent findings in hearing technology allow for people to either use a hearing aid or a Contralateral Routing of Signal (CROS) device on the non-implanted ear. Differences in speech understanding may result depending on the device chosen by a person, and these differences may be measureable through speech discrimination measurement methods. This study intends to determine whether or not a CROS device improves speech perception in noise when the source of the speech of interest originates from the side of the head opposite to the implant.

Interventions

DEVICECROS

Advanced Bionics CROS

DEVICEHearing Aid

Advanced Bionics Naida hearing aid

OTHERCochlear Implant Alone

No hearing device on contralateral ear

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be randomized into a group where they wear one of the processors and the order of conditions will be assessed, then they will switch to wear the other processor and the order of conditions will be assessed.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

\*: * An Advanced Bionics cochlear implant recipient with at least 6 months of listening experience * Low frequency Pure Tone Audiometry (PTA)

Exclusion criteria

\*: * Non-English speakers * Additional Inclusion and

Design outcomes

Primary

MeasureTime frameDescription
Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.12 minutesThe IEEE test allows a researcher to evaluate how well a subject understands sentences in noisy situations. Primary Outcome #1 will assess how well the listener can hear with his/her cochlear implant. The listener will be tested without a contralateral device versus also wearing a contralateral device while listening to sentences coming from various directions along with competing noise coming from various directions. The directions of the sentences or noise are as follows: * Omni: from all directions * Ipsi: the same side * Front * Contra: Contralateral, from the opposite side of the implant Visits are flexible, based on participant preference and may be completed any time between enrollment and end of study. Testing takes about 12 minutes.
CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.12 minutesThe IEEE test allows a researcher to evaluate how well a subject understands sentences in noisy situations. Primary Outcome #2 will assess how well the listener can hear wearing his/her cochlear implant and a CROS (Contralateral Routing of Signals device). A CROS is a device on the opposite ear that sends the nose to the cochlear implant. The listener will be tested without a contralateral device versus also wearing a contralateral device while listening to sentences coming from various directions along with competing noise coming from various directions. The directions of the sentences or noise are as follows: * Omni: from all directions * Ipsi: the same side * Front * Contra: Contralateral, from the opposite side of the implant Visits are flexible, based on participant preference and may be completed any time between enrollment and end of study. Testing takes about 12 minutes.
CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.12 minutesThe IEEE test allows a researcher to evaluate how well a subject understands sentences in noisy situations. Primary Outcome #3 will assess how well the listener can hear wearing his/her cochlear implant and hearing aid. The listener will be tested without a contralateral device versus also wearing a contralateral device while listening to sentences coming from various directions along with competing noise coming from various directions. The directions of the sentences or noise are as follows: * Omni: from all directions * Ipsi: the same side * Front * Contra: Contralateral, from the opposite side of the implant Visits are flexible, based on participant preference and may be completed any time between enrollment and end of study. Testing takes about 12 minutes.

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
All participants in crossover study.
25
Total25

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
Cognition/Memory Concern
Cognition/Memory Concern
3 Participants
Cognition/Memory Concern
Missing
1 Participants
Cognition/Memory Concern
No Concern
21 Participants
Contralateral Ear Device
Contralateral Routing of Signal (CROS) device
1 Participants
Contralateral Ear Device
Hearing Aid
19 Participants
Contralateral Ear Device
Nothing
5 Participants
Daily Use of Implant (hours)14.7 hours
STANDARD_DEVIATION 3.12
Diagnosis Related to Cognition/Memory
Has Diagnosis Related to Cognition/Memory
2 Participants
Diagnosis Related to Cognition/Memory
Missing
1 Participants
Diagnosis Related to Cognition/Memory
No Diagnosis Related to Cognition/Memory
22 Participants
Ear Protection with Excessive Noise
Ear Protection
3 Participants
Ear Protection with Excessive Noise
Missing
14 Participants
Ear Protection with Excessive Noise
No Ear Protection
8 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Exposure to Excessive Noise
Exposure to Excessive Noise
11 Participants
Exposure to Excessive Noise
No Exposure to Excessive Noise
14 Participants
Has Tinnitus
No Tinnitus
10 Participants
Has Tinnitus
Tinnitus
14 Participants
Has Tinnitus
Unknown
1 Participants
Head Trauma
Head Trauma
3 Participants
Head Trauma
Missing
1 Participants
Head Trauma
No Head Trauma
21 Participants
Hearing loss duration (years)29.7 years
STANDARD_DEVIATION 16.6
Implant Device
CII Bionic Ear
1 Participants
Implant Device
HiRes 90K
12 Participants
Implant Device
HiRes Ultra with HiFocus 1J
8 Participants
Implant Device
HiRes Ultra with HiFocus Mid-Scal
4 Participants
Implant Side
Left
9 Participants
Implant Side
Right
16 Participants
PTA: Cochlear Implant Alone
High Frequency PTA
28.2 dB
STANDARD_DEVIATION 4.87
PTA: Cochlear Implant Alone
Low Frequency PTA
31.1 dB
STANDARD_DEVIATION 7
PTA: Cochlear Implant Alone
PTA (avg 500, 1000, 2000)
29.5 dB
STANDARD_DEVIATION 5.67
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
24 Participants
Region of Enrollment
United States
25 participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
13 Participants
Tinnitus Ears
Both
8 Participants
Tinnitus Ears
Left
1 Participants
Tinnitus Ears
None/Missing
11 Participants
Tinnitus Ears
Not Sure
3 Participants
Tinnitus Ears
Right
2 Participants
Tinnitus Frequency
Constant
7 Participants
Tinnitus Frequency
Intermittent
6 Participants
Tinnitus Frequency
Missing
11 Participants
Tinnitus Frequency
Not Sure
1 Participants
Unaided Left PTA
High Frequency PTA
99.3 dB
STANDARD_DEVIATION 23.5
Unaided Left PTA
Low Frequency PTA
77.0 dB
STANDARD_DEVIATION 33.5
Unaided Left PTA
PTA (avg 500, 1000, 2000)
94.0 dB
STANDARD_DEVIATION 24.1
Unaided Right PTA
High Frequency PTA
98.8 dB
STANDARD_DEVIATION 23.2
Unaided Right PTA
Low Frequency PTA
80.5 dB
STANDARD_DEVIATION 28.3
Unaided Right PTA
PTA (avg 500, 1000, 2000)
94.0 dB
STANDARD_DEVIATION 23.8
Years since first hearing aid fit20.8 years
STANDARD_DEVIATION 14.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 250 / 25
other
Total, other adverse events
0 / 250 / 250 / 25
serious
Total, serious adverse events
0 / 250 / 250 / 25

Outcome results

Primary

CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.

The IEEE test allows a researcher to evaluate how well a subject understands sentences in noisy situations. Primary Outcome #2 will assess how well the listener can hear wearing his/her cochlear implant and a CROS (Contralateral Routing of Signals device). A CROS is a device on the opposite ear that sends the nose to the cochlear implant. The listener will be tested without a contralateral device versus also wearing a contralateral device while listening to sentences coming from various directions along with competing noise coming from various directions. The directions of the sentences or noise are as follows: * Omni: from all directions * Ipsi: the same side * Front * Contra: Contralateral, from the opposite side of the implant Visits are flexible, based on participant preference and may be completed any time between enrollment and end of study. Testing takes about 12 minutes.

Time frame: 12 minutes

Population: One participant did not have data collected while wearing the contralateral device. Data is only available for 5 participants in the No Contralateral Device group. The PI has left the institution and multiple attempts to contact the PI or ascertain why only 5 participants were assessed for this group have been unsuccessful. This is the only data that can be provided.

ArmMeasureGroupValue (MEAN)Dispersion
No Contralateral Device (Cochlear Implant Alone)CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Contra Speech, Ipsi Noise12.9 ratioStandard Deviation 10.3
No Contralateral Device (Cochlear Implant Alone)CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Front Speech, Front Noise15.3 ratioStandard Deviation 6.29
No Contralateral Device (Cochlear Implant Alone)CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Contra Speech, Omni9.9 ratioStandard Deviation 9.96
No Contralateral Device (Cochlear Implant Alone)CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Front Speech, Omni Noise10.7 ratioStandard Deviation 4.65
No Contralateral Device (Cochlear Implant Alone)CI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Ipsi Speech, Omni Noise9.7 ratioStandard Deviation 7.17
Cochlear Implant and Contralateral DeviceCI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Front Speech, Omni Noise13.5 ratioStandard Deviation 8.5
Cochlear Implant and Contralateral DeviceCI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Ipsi Speech, Omni Noise13.7 ratioStandard Deviation 8.92
Cochlear Implant and Contralateral DeviceCI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Contra Speech, Ipsi Noise16.6 ratioStandard Deviation 7.65
Cochlear Implant and Contralateral DeviceCI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Contra Speech, Omni13.1 ratioStandard Deviation 8.2
Cochlear Implant and Contralateral DeviceCI CROS: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CICROS, Front Speech, Front Noise16.0 ratioStandard Deviation 7.26
Primary

CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.

The IEEE test allows a researcher to evaluate how well a subject understands sentences in noisy situations. Primary Outcome #3 will assess how well the listener can hear wearing his/her cochlear implant and hearing aid. The listener will be tested without a contralateral device versus also wearing a contralateral device while listening to sentences coming from various directions along with competing noise coming from various directions. The directions of the sentences or noise are as follows: * Omni: from all directions * Ipsi: the same side * Front * Contra: Contralateral, from the opposite side of the implant Visits are flexible, based on participant preference and may be completed any time between enrollment and end of study. Testing takes about 12 minutes.

Time frame: 12 minutes

Population: Data could not be collected for one participant while wearing the Contralateral Device for condition CIHA, Contra Speech, Omni Noise. Data is only available for 5 participants in the No Contralateral Device group. The PI has left the institution and multiple attempts to contact the PI or ascertain why only 5 participants were assessed for this group have been unsuccessful. This is the only data that can be provided.

ArmMeasureGroupValue (MEAN)Dispersion
No Contralateral Device (Cochlear Implant Alone)CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Contra Speech, Ipsi Noise16.4 ratioStandard Deviation 8.19
No Contralateral Device (Cochlear Implant Alone)CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Front Speech, Front Noise14.0 ratioStandard Deviation 6.78
No Contralateral Device (Cochlear Implant Alone)CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Contra Speech, Omni Noise11.6 ratioStandard Deviation 10.1
No Contralateral Device (Cochlear Implant Alone)CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Front Speech, Omni Noise8.65 ratioStandard Deviation 6.67
No Contralateral Device (Cochlear Implant Alone)CI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Ipsi Speech, Omni Noise8.62 ratioStandard Deviation 10.5
Cochlear Implant and Contralateral DeviceCI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Front Speech, Omni Noise9.51 ratioStandard Deviation 7.49
Cochlear Implant and Contralateral DeviceCI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Ipsi Speech, Omni Noise9.05 ratioStandard Deviation 7.06
Cochlear Implant and Contralateral DeviceCI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Contra Speech, Ipsi Noise16.9 ratioStandard Deviation 8.44
Cochlear Implant and Contralateral DeviceCI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Contra Speech, Omni Noise11.5 ratioStandard Deviation 8.17
Cochlear Implant and Contralateral DeviceCI HA: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CIHA, Front Speech, Front Noise14.6 ratioStandard Deviation 6.62
Primary

Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.

The IEEE test allows a researcher to evaluate how well a subject understands sentences in noisy situations. Primary Outcome #1 will assess how well the listener can hear with his/her cochlear implant. The listener will be tested without a contralateral device versus also wearing a contralateral device while listening to sentences coming from various directions along with competing noise coming from various directions. The directions of the sentences or noise are as follows: * Omni: from all directions * Ipsi: the same side * Front * Contra: Contralateral, from the opposite side of the implant Visits are flexible, based on participant preference and may be completed any time between enrollment and end of study. Testing takes about 12 minutes.

Time frame: 12 minutes

Population: One participant did not have data collected while wearing the contralateral device. Data is only available for 5 participants in the No Contralateral Device group. The PI has left the institution and multiple attempts to contact the PI or ascertain why only 5 participants were assessed for this group have been unsuccessful. This is the only data that can be provided.

ArmMeasureGroupValue (MEAN)Dispersion
No Contralateral Device (Cochlear Implant Alone)Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Ipsi Speech, Omni Noise8.45 ratioStandard Deviation 11.4
No Contralateral Device (Cochlear Implant Alone)Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Contra Speech, Ipsi Noise21.2 ratioStandard Deviation 6.99
No Contralateral Device (Cochlear Implant Alone)Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Contra Speech, Omni Noise15.5 ratioStandard Deviation 8.85
No Contralateral Device (Cochlear Implant Alone)Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Front Speech, Front Noise15.8 ratioStandard Deviation 7.04
No Contralateral Device (Cochlear Implant Alone)Cochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Front Speech, Omni Noise8.85 ratioStandard Deviation 5.95
Cochlear Implant and Contralateral DeviceCochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Front Speech, Omni Noise12.6 ratioStandard Deviation 8.27
Cochlear Implant and Contralateral DeviceCochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Front Speech, Front Noise17.1 ratioStandard Deviation 6.94
Cochlear Implant and Contralateral DeviceCochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Contra Speech, Ipsi Noise22.2 ratioStandard Deviation 6.17
Cochlear Implant and Contralateral DeviceCochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Ipsi Speech, Omni Noise10.4 ratioStandard Deviation 9.5
Cochlear Implant and Contralateral DeviceCochlear Implant: Signal to Noise Ratio (SNR) Threshold Obtained From IEEE (Speech Perception in Noise Test) Sentence in Noise Test.CI, Contra Speech, Omni Noise15.9 ratioStandard Deviation 7.73

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026